BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Keyword: Recurrent hepatocellular carcinoma
1
Treatment of recurrent hepatocellular carcinoma: The current standards and future perspectives  
11/14/2025 12:56:17 AM | Browse: 24 | Download: 55
2
Recent advances in recurrent hepatocellular carcinoma therapy
4/20/2023 7:26:29 AM | Browse: 305 | Download: 1054
3
Immunotherapy for advanced or recurrent hepatocellular carcinoma
3/15/2023 2:14:31 AM | Browse: 311 | Download: 1006
4
Transcriptome analysis creates a new era of precision medicine for managing recurrent hepatocellular carcinoma
2/6/2023 12:22:17 PM | Browse: 312 | Download: 1031
5
Salvage locoregional therapies for recurrent hepatocellular carcinoma
1/12/2023 10:19:09 AM | Browse: 312 | Download: 863
6
Combining local regional therapy and systemic therapy: Expected changes in the treatment landscape of recurrent hepatocellular carcinoma
1/10/2023 8:49:38 AM | Browse: 310 | Download: 914
7
Study on the clinical stages of recurrent hepatocellular carcinoma: A retrospective cohort study
9/16/2021 8:48:21 AM | Browse: 452 | Download: 1546
8
Anti-programmed cell death ligand 1-based immunotherapy in recurrent hepatocellular carcinoma with inferior vena cava tumor thrombus and metastasis: Three case reports
7/21/2021 8:24:10 AM | Browse: 774 | Download: 2107
9
Successful hepatic resection for recurrent hepatocellular carcinoma after lenvatinib treatment: A case report
12/18/2020 5:58:43 AM | Browse: 802 | Download: 1541
10
Managements of recurrent hepatocellular carcinoma after liver transplantation: A systematic review
12/10/2015 10:17:00 AM | Browse: 1403 | Download: 3156
Write to the Help Desk
© 1993-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345